Effectiveness of a modified version of the applied relaxation technique in treatment of perimenopausal and postmenopausal symptoms

International Journal of Women's Health

Volumn 5, Issue 1, 2013, Pages 765-771

  Saensak, Suprawita ^a,b   Vutyavanich, Teraporn ^b   Somboonporn, Woraluk ^c   Srisurapanont, Manit ^b  

^a MAHASARAKHAM UNIVERSITY   (Thailand)

^b CHIANG MAI UNIVERSITY   (Thailand)

^c KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Alternative treatments; Applied relaxation; Hot flashes; Menopausal symptoms

Indexed keywords

ADULT; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOT FLUSH; HUMAN; MENOPAUSAL SYNDROME; NIGHT SWEAT; OPEN STUDY; OUTCOME VARIABLE; PARALLEL DESIGN; PATIENT MONITORING; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RELAXATION TRAINING; SCORING SYSTEM; SLEEP DISORDER; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 84887343227     PISSN: None     EISSN: 11791411     Source Type: Journal    
DOI: 10.2147/IJWH.S53652     Document Type: Article

References (27)

1. McKinlay MS, Brambilla JD, Posner J. The normal menopause transition. Maturitas. 1992;14(2):103-115.
2. Freeman EW, Sammel MD, Lin H, etal. Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol. 2007;110(2 Pt 1):230-240.
3. Kaufert AP, Gilbert P. The Manitoba Project: a re-examination of the link between menopause and depression. Maturitas. 1992;14(2):143-155.
4. Dennerstein L, Smith MA, Morse AC, etal. Menopausal symptoms in Australian women. Med J Aust. 1993;159(4):232-236.
5. Lopez FJ, Finn PD, Lawson MA, Negro-Vilar A. Regulation of the hypothalamic-pituitary-gonadal axis: role of gonadal steroids and implications for the menopause. In: Lobo RA, Kelsey J, editors. Menopause: Biology and Pathobiology. San Diego, CA: Academic Press; 2000.
6. Dennerstein L, Dudley E, Hopper J, Guthrie J, Burger H. A prospective population-based study of menopausal symptoms. Obstet Gynecol. 2000;96(3):351-358.
7. Gold BE, Sternfeld B. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol. 2000;152(5):463-473.
8. Col NF, Guthrie JR, Politi M, Dennerstein L. Duration of vasomotor symptoms in middle-aged women: a longitudinal study. Menopause. 2009;16:453-457.
9. Soules MR, Sherman S, Parrott E, etal. Executive summary: stages of reproductive aging workshop (STRAW) Park City, Utah, Jul 2001. Menopause. 2001;8(6):402-407.
10. Hickey M, Davis SR, Sturdee DW. Treatment of menopausal symptoms: what shall we do now? Lancet. 2005;366(9483):409-421.
11. Rossouw JE, Anderson GL, Prentice RL, etal. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Control Trial. JAMA. 2002;288(3):321-333.
12. North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause. 2004;11(1):11-33.
13. Newton K, Buist DS, Keenan NL, Anderson LA, LaCroix AZ. Use of alternative therapies for menopause symptoms: results of a population based survey. Obstet Gynecol. 2002;100(1):18-25.
14. Blair YA, Gold EB, Azari RA, etal. Use of conventional and complimentary health care during the transition to menopause: longitudinal results from the Study of Women's Health Across the Nation (SWAN). Menopause. 2005;12(1):31-39.
15. Daley AJ, MacArthur C, McManus R, etal. Factors associated with the use of complementary medicine and non-pharmacological interventions in symptomatic menopausal women. Climacteric. 2006;9(5): 336-346.
16. Hoffman WJ, Benson H, Arns AP. Reduced sympathetic nervous system responsivity associated with the relaxation response. Science. 1981;215(4529):190-192.
17. Nedstrand E, Wijma K, Wyon Y, Hammar M. Applied relaxation and oral estradiol treatment of vasomotor symptoms in postmenopausal women. Maturitas. 2005;51(2):154-162.
18. Freedman RR, Woodward S, Brown B, Javaid IJ, Pandey GN. Biochemical and thermoregulatory effects of behavioral treatment for menopausal hot flushes. Menopause. 1995;2(4):211-218.
19. Innes KE, Selfe TK, Vishnu A. Mind-body therapies for menopausal symptoms: a systematic review. Maturitas. 2010;66(2):135-149.
20. Lachin JM. Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials. 1981;2(2):93-113.
21. Germaine LM, Freedman RR. Behavioral treatment of menopausal hot flashes: evaluation by objective methods. J Consult Clin Psychol. 1984;52(6):1072-1079.
22. Nedstrand E, Wijma K, Wyon Y, Hammar M. Vasomotor symptoms decrease in women with breast cancer randomized to treatment with applied relaxation or electro-acupuncture: a preliminary study. Climacteric. 2005;8(3):243-250.
23. Zaborowska E, Brynhildsen J, Damberg S, etal. Effects of acupuncture, applied relaxation, estrogens and placebo on hot flush in postmenopausal women: an analysis of prospective, parallel randomized studied. 2007;10(1):38-45.
24. McCormack HM, Horne DJ, Sheather S. Clinical applications of visual analogue scales: a critical review. Psychol Med. 1988;18(4): 1007-1019.
25. Freedman RR, Woodward S. Behavioral treatment of menopausal hot flushes: evaluation by ambulatory monitoring. Am J Obstet Gynecol. 1992;167(2):436-439.
26. Hunter M, Liao KLM. Evaluation of four session cognitive behavioral intervention for menopausal hot flushes. Br J Health Psychol. 1996;1: 113-125.
27. D'Zurilla, Goldfried TJ, Marvin R. Problem solving and behavior modification. J Abnorm Psychol. 1971;78(1):107-126.